Overall annual cardiac mortality in hypertrophic cardiomyopathy (HC) has been reported to be between 2 and 4%, although these numbers are primarily from retrospective studies of patients referred to large research institutions. A clinic population of 113 patients with HC was prospectively studied to assess cardiac mortality in the overall group and in selected subgroups commonly thought to be at high risk for sudden death. The mean age at diagnosis was 37 ± 16 years. During follow-up, there were 11 cardiac and 2 noncardiac deaths. The annual cardiac mortality was 1% (95% confidence interval 0.2–1.8%). Because of the small number of deaths, relative risk for cardiac death was not significantly different in the presence of young age (≤30 year...
Abstract Aims We aim to clarify the prognosis on patients with hypertrophic cardiomyopathy (HCM) for...
textabstractHypertrophic cardiomyopathy (HCM) is an intriguing disease due to its heterogeneity in g...
Background: Patients with hypertrophic cardiomyopathy (HCM) are generally regarded as having increas...
textabstractOverall annual cardiac mortality in hypertrophic cardiomyopathy (HC) has been reported t...
AbstractObjectivesThis study evaluates the clinical course and identifies risk factors for sudden ca...
AbstractObjectives. We investigated the long-term prognosis of completely asymptomatic adult patient...
In the early years of the disease recognition, hypertrophic cardiomyopathy (HCM) was viewed as an om...
Most available information on the clinical course and prognosis of hypertrophic cardiomyopathy (HCM)...
Objectives.Our aim was to study a population of patients with hypertrophic cardiomyopathy from the w...
The prognosis of patients diagnosed as having hypertrophic cardiomyopathy at advanced age has not be...
AbstractObjectivesThis study was designed to clarify and resolve the clinical profile of older patie...
Patients with hypertrophic cardiomyopathy (HC) are reported to have a mortality rate of about 1.0% p...
AbstractObjectives. We sought to determine clinical, angiographic, and echocardiographic predictors ...
AbstractBackgroundHypertrophic cardiomyopathy (HCM) has been prominently associated with adverse dis...
Patients with hypertrophic cardiomyopathy (HC) are reported to have a mortality rate of about 1.0% p...
Abstract Aims We aim to clarify the prognosis on patients with hypertrophic cardiomyopathy (HCM) for...
textabstractHypertrophic cardiomyopathy (HCM) is an intriguing disease due to its heterogeneity in g...
Background: Patients with hypertrophic cardiomyopathy (HCM) are generally regarded as having increas...
textabstractOverall annual cardiac mortality in hypertrophic cardiomyopathy (HC) has been reported t...
AbstractObjectivesThis study evaluates the clinical course and identifies risk factors for sudden ca...
AbstractObjectives. We investigated the long-term prognosis of completely asymptomatic adult patient...
In the early years of the disease recognition, hypertrophic cardiomyopathy (HCM) was viewed as an om...
Most available information on the clinical course and prognosis of hypertrophic cardiomyopathy (HCM)...
Objectives.Our aim was to study a population of patients with hypertrophic cardiomyopathy from the w...
The prognosis of patients diagnosed as having hypertrophic cardiomyopathy at advanced age has not be...
AbstractObjectivesThis study was designed to clarify and resolve the clinical profile of older patie...
Patients with hypertrophic cardiomyopathy (HC) are reported to have a mortality rate of about 1.0% p...
AbstractObjectives. We sought to determine clinical, angiographic, and echocardiographic predictors ...
AbstractBackgroundHypertrophic cardiomyopathy (HCM) has been prominently associated with adverse dis...
Patients with hypertrophic cardiomyopathy (HC) are reported to have a mortality rate of about 1.0% p...
Abstract Aims We aim to clarify the prognosis on patients with hypertrophic cardiomyopathy (HCM) for...
textabstractHypertrophic cardiomyopathy (HCM) is an intriguing disease due to its heterogeneity in g...
Background: Patients with hypertrophic cardiomyopathy (HCM) are generally regarded as having increas...